BCL2 and neoplasm: Our previous study reported miR-206 could also target 3′-UTR of MET and BCL2, and activate apoptosis, inhibit tumor cell proliferation, migration and colony formation in NSCLC cell lines (A549 and SK-MES-1) [46].